| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0414190425892871 | 0.15606007 |
| NSC 732178 | Null | 0.0414190425892871 | 0.1840922 |
| NSC 740 | Methotrexate | 0.0414190425892871 | 0.42129604 |
| NSC 740476 | Null | 0.0414190425892871 | 0.14241594 |
| NSC 744063 | Null | 0.0414190425892871 | 0.21729684 |
| NSC 746053 | Null | 0.0414190425892871 | 0.1935347 |
| NSC 31768 | Null | 0.0421163101172308 | -0.056074208 |
| NSC 641052 | Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) | 0.0421163101172308 | 0.1322942 |
| NSC 658420 | Null | 0.0421163101172308 | 0.097295799 |
| NSC 665694 | 2-Propen-1-one, 1-(4-hydroxyphenyl)- 3-[4-(dimethylamino)phenyl]- | 0.0421163101172308 | 0.5410379 |